Search

Doris B Bucher

from Sacramento, CA
Deceased
Get Report
Also known as:
Doris E Bucher
Phone and address:
8506 Dierks Rd, Sacramento, CA 95830
Related to:
Hary AntwilerWilliam C Flanigan, 35Jennifer Antwiler, 50Katherine Waldorf, 64
Connected to:
Alyssa Bucher, 30Audrey Bucher, 37Brenda L Bucher, 67Cindy E Bucher, 57Claudia R Bucher, 80Cori L Bucher, 41Dayle E Bucher, 72Deborah A Bucher, 68Denice L Bucher, 64Foster O Bucher, 74

Doris Bucher Phones & Addresses

  • 8506 Dierks Rd, Sacramento, CA 95830
  • Reno, NV
  • Monte Rio, CA
  • El Granada, CA
  • 5666 La Campana Way, Sacramento, CA 95822

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Publications

Us Patents

Synthetic Peptides For Diagnosis And Prevention Of Influenza Virus Infection And Their Use

View page
US Patent:
51360195, Aug 4, 1992
Filed:
May 24, 1989
Appl. No.:
7/356981
Inventors:
Amrit K. Judd - Belmont CA
Doris J. Bucher - New York NY
Assignee:
SRI International - Menlo Park CA
International Classification:
C07K 700
A61K 3700
US Classification:
530326
Abstract:
Synthetic polypeptides having influenza virus antigenic properties are disclosed. These polypeptides correspond substantially to the 215 to 235 region of the matrix protein of influenza virus. Salts, derivatives, and conjugates of these polypeptides are disclosed as well as methods for using these materials for diagnostic and medical/veterinary purposes.

Conjugates Of A Synthetic Peptide For Diagnosis And Prevention Of Influenza Virus Infection

View page
US Patent:
52430308, Sep 7, 1993
Filed:
Apr 24, 1992
Appl. No.:
7/874295
Inventors:
Amrit K. Judd - Belmont CA
Doris J. Bucher - New York NY
Assignee:
SRI International - Menlo Park CA
International Classification:
C12N 996
C07K 1700
A61K 3700
US Classification:
530403
Abstract:
Macromolecular conjugates of a synthetic polypeptide having influenza virus antigenic properties are disclosed. These conjugates contain a polypeptide corresponding substantially to the 215-235 region of the matrix protein (M-protein) of influenza virus.

Synthetic Peptides For Diagnosis And Prevention Of Influenza Virus Infection And Their Use

View page
US Patent:
49817825, Jan 1, 1991
Filed:
May 14, 1987
Appl. No.:
7/050633
Inventors:
Amrit K. Judd - Belmont CA
Doris J. Bucher - New York NY
Steven W. Popple - Brooklyn NY
Assignee:
SRI International - Menlo Park CA
International Classification:
C12Q 170
G01N 33536
G01N 33531
C07K 708
US Classification:
435 5
Abstract:
Synthetic polypeptides having influenza virus antigenic properties are disclosed. These polypeptides correspond substantially to particular regions in the matrix protein of influenza virus. Salts, derivatives, and conjugates of these polypeptides are disclosed as well as methods for using these materials for diagnostic and medical/veterinary purposes.

M-Protein Peptides Of Influenza Virus As Antiviral Agents

View page
US Patent:
56163274, Apr 1, 1997
Filed:
Nov 7, 1994
Appl. No.:
8/335303
Inventors:
Amrit K. Judd - Belmont CA
Doris J. Bucher - New York NY
Assignee:
SRI International - Menlo Park CA
New York Medical College - Valhalla NY
International Classification:
A61K 39385
A61K 3810
A61K 9127
C07K 1702
US Classification:
4242061
Abstract:
Peptides substantially corresponding to the 148-162 region of type A influenza M protein and additionally containing at least one amino acid in the 163-166 region are disclosed to have high activity as influenza transcription inhibitors and thus as antiviral agents against influenza virus and other RNA viruses. The modification of these peptides by incorporation into liposomes or by addition of long-chain alkylamino acids is also shown as in the use of all such materials in antiviral drug formulations.

Influenza Vaccine And Therapy

View page
US Patent:
20170035876, Feb 9, 2017
Filed:
Sep 22, 2016
Appl. No.:
15/272790
Inventors:
- Redwood City CA, US
Mark Baer - San Francisco CA, US
Doris Bucher - New York NY, US
Geoffrey Yarranton - Burlingame CA, US
Assignee:
EnGen Bio, LLC - Redwood City CA
International Classification:
A61K 39/145
Abstract:
The present invention is directed generally to M1 polypeptides that can be utilized as vaccines and/or antigens for generation of anti-M1 polypeptide antibodies for prophylactic treatment of individuals who are susceptible to infection by influenza virus. The anti-M1 polypeptide antibodies of the invention are useful for treatment of individuals infected with influenza virus, or useful for prophylactic treatment of individuals who are susceptible to infection by influenza virus, or for immune-suppressed individuals who cannot generate an effective antibody response.

Influenza Vaccine And Therapy

View page
US Patent:
20150086560, Mar 26, 2015
Filed:
Sep 21, 2014
Appl. No.:
14/492068
Inventors:
- Redwood City CA, US
Mark Baer - San Francisco CA, US
Doris Bucher - New York NY, US
International Classification:
A61K 39/145
C07K 16/10
US Classification:
4241391, 4241591, 4241861, 4242091, 5303879, 5303873
Abstract:
The present invention is directed generally to M1 polypeptides that can be utilized as vaccines and/or antigens for generation of anti-M1 polypeptide antibodies for prophylactic treatment of individuals who are susceptible to infection by influenza virus. The anti-M1 polypeptide antibodies of the invention are useful for treatment of individuals infected with influenza virus, or useful for prophylactic treatment of individuals who are susceptible to infection by influenza virus, or for immune-suppressed individuals who cannot generate an effective antibody response.
Control profile
Doris B Bucher from Sacramento, CADeceased Get Report